Hermona Soreq, Yonatan Loewenstein, and Hebrew University of Jerusalem colleagues have uncovered a sex-specific molecular mechanism leading to accelerated cognitive decline in women with Alzheimer’s disease. Current therapeutic protocols are based on structural changes in...
Sheng Xu and colleagues have developed a wearable, stretchable device that non-invasively evaluates the stiffness of human tissue, at an improved penetration depth, and for a longer period than, existing methods. An ultrasonic array facilitates serial,...
Aviv Mezer and Hebrew University colleagues used quantitative MRI to identify cellular changes in Parkinson’s disease. Their method enabled them to look at microstructures in the striatum, which is known to deteriorate during disease progression....
In a recent study, Boston University professor Robert Reinhart used tACS to stimulate brain activity in 150 people aged 65-88, resulting in memory improvements for one month. Stimulating the dorsolateral prefrontal cortex improved long-term memory, while stimulating...
MIT’s Dina Katabi has developed a non-contact, neural network-based system to detect Parkinson’s disease while a person is sleeping. By assessing nocturnal breathing patterns, the series of algorithms detects, and tracks the progression of, the disease —...
Heibei University, Tianjin Hospital, Beihang University, and Penn State researchers have developed an under nose-worn, stretchable, skin-friendly, waterproof sensor to analyze breath for health monitoring. It could be use for multiple-condition screening, asthma and COPD management,...
On July 6, 2022, Mount Sinai’s Shahram Majidi threaded Synchron‘s 1.5-inch-long, wire and electrode implant into a blood vessel in the brain of a patient with ALS. The goal is for the patient, who cannot speak or...
Deji Akinwande, Roozbeh Jafari, and UT Austin colleagues have developed an electronic wrist tattoo that can be worn for hours and deliver highly accurate, continuous blood pressure measurements. This can provide a much clearer picture of...
Early Parkinson’s Disease patients benefit significantly from levodopa, to replace dopamine to restore normal motor function. As PD progresses, the brain loses more dopamine-producing cells, which causes motor complications and unpredictable responses to levodopa....
Ruhr University professor Sebastian Kruss, with Max Planck researchers Sofia Elizarova and James Daniel, has developed a sensor that can visualize the release of dopamine from nerve cells with unprecedented resolution. The team used modified carbon...